RFM
BIIB icon

Royal Fund Management’s Biogen BIIB Stock Holding History

Royal Fund Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4
Closed – – 547
2019
Q1 		$0 Hold
4
– – ﹤0.01% 590
2018
Q4 		$1K Buy
+4
New +$1.28K ﹤0.01% 510
2018
Q3 		– Sell
-6
Closed -$1K – 523
2018
Q2 		$1K Hold
6
– – ﹤0.01% 504
2018
Q1 		$1K Sell
6
-2
-25% -$621 ﹤0.01% 472
2017
Q4 		$2K Buy
+8
New +$2.57K ﹤0.01% 567

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royal Fund Management's BIIB Position: Q2 2019 in Review

Royal Fund Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 4 shares.

Royal Fund Management first reported a position in BIIB in Q4 2017 and held it in 5 quarters. The position peaked at $2K in Q4 2017. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Royal Fund Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Royal Fund Management sold 4 Biogen shares in Q2 2019.
  • Royal Fund Management first reported a position in Biogen in Q4 2017 and held it in 5 quarters.
  • Royal Fund Management's Biogen position peaked at $2K in Q4 2017.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Royal Fund Management's 13F filing for Q2 2019, filed 8 May 2020.